Age-related changes in the face are manifested not only by wrinkles or deterioration in the quality of the skin, but also by a deformed contour. Under the influence of gravitational forces and a number of other reasons, a redistribution of adipose tissue occurs, which accumulates in the region of the middle and lower thirds of the face. Because of this, the oval of the face loses its clarity, characteristic of youth. Plastic surgeons are well aware of how to improve the oval of the face, but not every patient is ready for radical measures to correct their appearance, so lipolytic injections are a success. How do these cocktails work and why MESOSCULPTTM C71 – a new class drug that affects adipose tissue at the gene level has an advantage over them, estet-portal.com found out.
How to improve the oval of the face: features of injection fight against fat
Age-related changes in the face are manifested not only by wrinkles or deterioration in the quality of the skin, but also by a deformed contour, this is largely due to involutional changes in adipose tissue in superficial and deep fat packages. Simultaneously with the migration of fat packages, a redefinition of the volume in them occurs: mainly atrophy of deep fat packages and hypertrophy of the superficial – nasolabial, lateral and medial mandibular, submandibular. Accumulations of fat in these packages significantly distort the contours and volumes of the face, form the so-called "flews"; and "double chin".
In order to correct the features and return the face to the image it was in youth, various methods of influencing adipose tissue are practiced.
Many patients are not ready for surgical correction and prefer minimally invasive methods, so injectable drugs with lipolytic properties have become popular.
The essence of the work of lipolytics is the destruction of fat cells directly at the injection site. With the help of microinjections, a lipolytic drug is introduced into the adipose tissue, which dissolves the membranes of fat cells and the fat cells themselves. However, lipolytics are not specific to adipose tissue and, simultaneously with the destruction of fat cells, destruction of nearby skin cells, blood vessels, nerve cells and muscles can also occur. Also, many lipolytic drugs have serious contraindications:
- diseases of the heart and blood vessels;
- diseases of the liver and kidneys;
- problems in the functioning of the thyroid gland
- not recommended for use on the face above the chin and lower jaw.
The choice of a safe and effective agent that gently acts on enlarged adipose tissue remains with the doctor, and many specialists now opt for MESOSCULPTТМ C71, produced by the American laboratory ABG Lab, which is exclusively presented in our market by EMETТМ.
The advantages of MESOSCULPTТМ C71 are that it allows you to safely, significantly and permanently improve the contours and oval of the face
Main active ingredient MESOSCULPTТМ C71 – LipoBlock XP2 — a unique patented complex consisting of specially selected cosmetic ingredients in balanced proportions. Once in the adipose tissue, it reduces the size of each fat cell without destroying or destroying it, unlike other substances called lipolytics, which is safe and has a prolonged effect. This action does not exist in any other drug for reducing the volume of adipose tissue. The second active substance MESOSCULPTТМ C71 — Hexapeptide 17 – provides rapid removal of excess interstitial fluid from adipose tissue,
ТМ C71 belongs to the class of lipomodifiers, since the drug does not destroy adipose tissue, but allows you to control the processes occurring in it at the gene level.
Unlike other products, MESOSCULPTThe uniqueness of the action of the components of the drug MESOSCULPTТМ C71 modifies the vital activity of fat cells: blocks their growth, reduces their size and does not allow their number to increase, but does not destroy it
ТМ C71 lies in the genetic control of the processes of formation of new fat cells and reduction in the size of existing adipocytes. At the same time, the body is not forced to remove the products of destruction of fat cells, as happens with lipolysis, when using direct lipolytics, therefore MESOSCULPTТМ C71 has no contraindications associated with the functioning of the liver and kidneys.
ТМ C71
A direct indication for the prescription of the injectable medical preparation MESOSCULPTТМ C71, presented by EMETTM,, are age-related changes associated with the formation subcutaneous fat deposits in the middle and lower thirds of the face. Gene regulation and control of adipose tissue in the lower and middle third of the face can significantly reduce its volume and maintain the stability of the result for a long time.
Add a comment